Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Raphael Pharmaceutical Inc | 18.1M | -6.4x | --- |
Curative Biotechnology Inc | 18.2M | -2.7x | --- |
Xilio Therapeutics Inc | 17.6M | -0.4x | --- |
Minerva Neurosciences Inc | 17.5M | -0.6x | --- |
Purple Biotech Ltd | 17.1M | -0.8x | --- |
CytoMed Therapeutics Ltd | 25.8M | -5.5x | --- |
Raphael Pharmaceutical Inc. is a pharmaceutical drug research and development company focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol (CBD) oil. The Company is in pre-clinical development stage for its lead product candidate, rheumatoid arthritis (RA), for the treatment of RA. It is engaged in developing a pharmaceutical drug product for the treatment of hyperinflammatory syndrome inflammation related to Covid-19, or Covid-19 product candidate, which may be based on data or studies related to RA product candidate. It uses CBD oil as the active pharmaceutical ingredient (API), for its RA and COVID-19 product candidate.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $18.1M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 18.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.16 |
Book Value | $0.01 |
P/E Ratio | -6.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.